Jill K. Burton

991 total citations
14 papers, 677 citations indexed

About

Jill K. Burton is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Jill K. Burton has authored 14 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Jill K. Burton's work include Thyroid Cancer Diagnosis and Treatment (4 papers), Renal cell carcinoma treatment (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Jill K. Burton is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (4 papers), Renal cell carcinoma treatment (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Jill K. Burton collaborates with scholars based in United States, Singapore and France. Jill K. Burton's co-authors include Keith C. Bible, Charles Erlichman, Vera J. Suman, Michael E. Menefee, William J. Maples, Robert C. Smallridge, Julian R. Molina, Kostandinos Sideras, Kevin Webster and Anne M. Traynor and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and The Lancet Oncology.

In The Last Decade

Jill K. Burton

12 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jill K. Burton United States 9 429 330 155 136 110 14 677
Kanchan Puttaswamy United States 7 472 1.1× 264 0.8× 94 0.6× 197 1.4× 106 1.0× 10 718
Federica Panebianco United States 11 387 0.9× 183 0.6× 114 0.7× 144 1.1× 138 1.3× 16 593
Matti L. Gild Australia 16 511 1.2× 254 0.8× 97 0.6× 208 1.5× 98 0.9× 53 824
Ann W. Gramza United States 10 206 0.5× 200 0.6× 181 1.2× 137 1.0× 81 0.7× 22 552
Bhumsuk Keam South Korea 9 247 0.6× 312 0.9× 134 0.9× 98 0.7× 50 0.5× 17 568
Sylwia Szpak‐Ulczok Poland 14 358 0.8× 112 0.3× 74 0.5× 255 1.9× 107 1.0× 28 645
Ronald A. Ghossein United States 6 686 1.6× 288 0.9× 130 0.8× 267 2.0× 141 1.3× 8 1.0k
So Young Rha South Korea 5 230 0.5× 181 0.5× 111 0.7× 151 1.1× 40 0.4× 8 433
Milan Mangeshkar United States 9 194 0.5× 289 0.9× 369 2.4× 217 1.6× 58 0.5× 17 655
Yansong Lin China 19 903 2.1× 204 0.6× 113 0.7× 209 1.5× 113 1.0× 104 1.1k

Countries citing papers authored by Jill K. Burton

Since Specialization
Citations

This map shows the geographic impact of Jill K. Burton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill K. Burton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill K. Burton more than expected).

Fields of papers citing papers by Jill K. Burton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill K. Burton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill K. Burton. The network helps show where Jill K. Burton may publish in the future.

Co-authorship network of co-authors of Jill K. Burton

This figure shows the co-authorship network connecting the top 25 collaborators of Jill K. Burton. A scholar is included among the top collaborators of Jill K. Burton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill K. Burton. Jill K. Burton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Konecny, Gottfried E., Coriolan Lebreton, Melissa C. Larson, et al.. (2025). Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancer. International Journal of Gynecological Cancer. 35(10). 102028–102028.
2.
Jasim, Sina, Vera J. Suman, Camilo Jiménez, et al.. (2017). Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paraganglioma. Endocrine. 57(2). 220–225. 49 indexed citations
3.
Konecny, Gottfried E., Andrea E. Wahner Hendrickson, Aminah Jatoi, et al.. (2016). A multicenter open-label phase II study of the efficacy and safety of palbociclib a cyclin-dependent kinases 4 and 6 inhibitor in patients with recurrent ovarian cancer.. Journal of Clinical Oncology. 34(15_suppl). 5557–5557. 25 indexed citations
4.
Kumar, Aditi, Jill K. Burton, Vera J. Suman, et al.. (2015). Effects of pazopanib therapy on mean corpuscular volume in patients enrolled in MC1112: Analysis of correlation with time to disease progression in solid tumors.. Journal of Clinical Oncology. 33(15_suppl). e13596–e13596.
5.
Koritala, Thoyaja, et al.. (2014). Efficacy and safety of the band and slough technique for endoscopic therapy of nonampullary duodenal adenomas: a case series. Gastrointestinal Endoscopy. 81(4). 985–988. 11 indexed citations
6.
Bible, Keith C., Vera J. Suman, Julian R. Molina, et al.. (2014). A multicenter international phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.. Journal of Clinical Oncology. 32(15_suppl). 6026–6026. 2 indexed citations
7.
Bible, Keith C., Prema P. Peethambaram, Ann L. Oberg, et al.. (2012). A Phase 2 Trial of Flavopiridol (Alvocidib) and Cisplatin in Platin-Resistant Ovarian and Primary Peritoneal Carcinoma: MC0261. Gynecologic Oncology. 127(1). 55–62. 46 indexed citations
8.
Bible, Keith C., Vera J. Suman, Michael E. Menefee, et al.. (2012). A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 97(9). 3179–3184. 131 indexed citations
9.
Bible, Keith C., Vera J. Suman, Julian R. Molina, et al.. (2010). Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study. The Lancet Oncology. 11(10). 962–972. 330 indexed citations
10.
Sideras, Kostandinos, Michael E. Menefee, Jill K. Burton, et al.. (2010). Effect of pazopanib on hair and skin hypopigmentation: A series of three patients.. Journal of Clinical Oncology. 28(15_suppl). e13602–e13602. 4 indexed citations
11.
Sideras, Kostandinos, Michael E. Menefee, Jill K. Burton, et al.. (2010). Profound Hair and Skin Hypopigmentation in an African American Woman Treated With the Multi-Targeted Tyrosine Kinase Inhibitor Pazopanib. Journal of Clinical Oncology. 28(19). e312–e313. 19 indexed citations
12.
Bible, Keith C., Robert C. Smallridge, William J. Maples, et al.. (2009). Phase II trial of pazopanib in progressive, metastatic, iodine-insensitive differentiated thyroid cancers. Journal of Clinical Oncology. 27(15_suppl). 3521–3521. 23 indexed citations
13.
Peethambaram, Prema P., Jill K. Burton, Ann L. Oberg, et al.. (2007). A phase 2 trial of flavopiridol and cisplatin in platinum-resistant ovarian cancer. 6. 1 indexed citations
14.
Robinow, Jay S., Edward G. Shaw, Robert T. Eagan, et al.. (1989). Results of combination chemotherapy and thoracic radiation therapy for unresectable non-small cell carcinoma of the lung. International Journal of Radiation Oncology*Biology*Physics. 17(6). 1203–1210. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kanchan Puttaswamy Breakdown of academic impact, for papers by Federica Panebianco Breakdown of academic impact, for papers by Matti L. Gild Breakdown of academic impact, for papers by Ann W. Gramza Breakdown of academic impact, for papers by Bhumsuk Keam Breakdown of academic impact, for papers by Sylwia Szpak‐Ulczok Breakdown of academic impact, for papers by Ronald A. Ghossein Breakdown of academic impact, for papers by So Young Rha Breakdown of academic impact, for papers by Milan Mangeshkar Breakdown of academic impact, for papers by Yansong Lin
Rankless by CCL
2026